CTRI/2024/08/072237尚未招募3 期
Post-operative intraperitoneal chemotherapy after interval cytoreduction in epithelial ovarian cancer (POICE 2024): multicenter, randomized, phase III trial - POICE 2024
Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patient giving informed consent
- •Newly diagnosed FIGO stage 3 or 4a epithelial ovarian cancer
- •After optimal cytoreduction after interval surgery
- •Must have received 3 or 4 cycles of paclitaxel nd carboplatin neoadjuvant chemotherapy
- •ECOG performance status 0 or 1 at enrolment
- •Negative pregnancy test in women of child bearing potential
- •adequate organ function
排除标准
- •Prior surgery for ovarian cancer other than biopsies
- •Serious medical illnesses
- •Uncontrolled infections
- •Pre existing neuropathy more than grade 1
- •Known to have borderline or low grade cancer
- •Prior partial therapy elsewhere
- •intraoperative complications rendering patient unfit for IP chemotherapy
- •Time from last chemotherapy to surgery less than 8 weeks
- •Bevacizumab as part of neoadjuvant schedule
研究者
相似试验
招募中
3 期
Post-operative intraperitoneal chemotherapy in epithelial ovarian cancerCTRI/2020/01/022955Jawaharlal Institute of Postgraduate Medical education and research
已完成
不适用
Peri-operative chemotherapy with intraperitoneal and intravenous Paclitaxel plus TS-1 for serosa positive gastric cancer patientsserosa positive gastric cancerJPRN-UMIN000013109Intraperitoneal chemotherapy study group50
已完成
不适用
The role of intra-abdominal chemotherapy in inoperable gastric cancer to change to operable tumorGastric cancer.Malignant neoplasm of stomachIRCT201107257112N1iver and Gastrointestinal Diseases Research Center40
尚未招募
2 期
Determining the efficacy and safety of neoadjuvant IP chemotherapy in rectal cancer patients with the spread of disease in peritoneumCTRI/2023/11/059575Tata Memorial Hospital
进行中（未招募）
1 期
Preoperative intraperitoneal chemotherapy in adjuvant hyperthermiaadjunctive therapy in advanced gastric cancer with high-risk of peritoneal recurrence - a multicentre randomized trialGastric CarcinomaMedDRA version: 21.0Level: LLTClassification code 10007350Term: Carcinoma gastricSystem Organ Class: 100000004864EUCTR2020-001419-25-PLJagiellonian University Medical College600